Thongnoppakhun Wanna, Limwongse Chanin, Vareesangthip Kriengsak, Sirinavin Chintana, Bunditworapoom Duangkamon, Rungroj Nanyawan, Yenchitsomanus Pa-thai
Division of Molecular Genetics, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
BMC Med Genet. 2004 Feb 3;5:2. doi: 10.1186/1471-2350-5-2.
We have previously developed a long RT-PCR method for selective amplification of full-length PKD1 transcripts (13.6 kb) and a long-range PCR for amplification in the reiterated region (18 kb) covering exons 14 and 34 of the PKD1 gene. These have provided us with an opportunity to study PKD1 mutations especially in its reiterated region which is difficult to examine. In this report, we have further developed the method of multiple restriction fragment-single strand conformation polymorphism (MRF-SSCP) for analysis of PKD1 mutations in the patients with autosomal dominant polycystic kidney disease (ADPKD). Novel and de novo PKD1 mutations are identified and reported.
Full-length PKD1 cDNA isolated from the patients with ADPKD was fractionated into nine overlapping segments by nested-PCR. Each segment was digested with sets of combined restriction endonucleases before the SSCP analysis. The fragments with aberrant migration were mapped, isolated, and sequenced. The presence of mutation was confirmed by the long-range genomic DNA amplification in the PKD1 region, sequencing, direct mutation detection, and segregation analysis in the affected family.
Five PKD1 mutations identified are two frameshift mutations caused by two di-nucleotide (c. 5225_5226delAG and c.9451_9452delAT) deletions, a nonsense (Q1828X, c.5693C>T) mutation, a splicing defect attributable to 31 nucleotide deletion (g.33184_33214del31), and an in-frame deletion (L3287del, c.10070_10072delCTC). All mutations occurred within the reiterated region of the gene involving exons 15, 26, 15, 19 and 29, respectively. Three mutations (one frameshift, splicing defect, and in-frame deletion) are novel and two (one frameshift and nonsense) known. In addition, two mutations (nonsense and splicing defect) are possibly de novo.
The MRF-SSCP method has been developed to analyze PCR products generated by the long RT-PCR and nested-PCR technique for screening PKD1 mutations in the full-length cDNA. Five mutations identified were all in the reiterated region of this gene, three of which were novel. The presence of de novo PKD1 mutations indicates that this gene is prone to mutations.
我们之前开发了一种长链RT-PCR方法用于选择性扩增全长PKD1转录本(13.6 kb),以及一种长距离PCR方法用于在覆盖PKD1基因外显子14和34的重复区域(18 kb)进行扩增。这些方法为我们研究PKD1突变提供了机会,尤其是在其难以检测的重复区域。在本报告中,我们进一步开发了多重限制性片段-单链构象多态性(MRF-SSCP)方法,用于分析常染色体显性多囊肾病(ADPKD)患者的PKD1突变。鉴定并报告了新的和新生的PKD1突变。
从ADPKD患者中分离的全长PKD1 cDNA通过巢式PCR被分成9个重叠片段。在进行SSCP分析之前,每个片段用组合限制性内切酶进行消化。对迁移异常的片段进行定位、分离和测序。通过PKD1区域的长距离基因组DNA扩增、测序、直接突变检测以及在患病家族中的分离分析来确认突变的存在。
鉴定出的5个PKD1突变中,有2个是由两个二核苷酸(c.5225_5226delAG和c.9451_9452delAT)缺失导致的移码突变,1个无义突变(Q1828X,c.5693C>T),1个由31个核苷酸缺失(g.33184_33214del31)导致的剪接缺陷,以及1个框内缺失(L3287del,c.10070_10072delCTC)。所有突变均发生在该基因的重复区域内,分别涉及外显子15、26、15、19和29。其中3个突变(1个移码突变、剪接缺陷和框内缺失)是新的,2个(1个移码突变和无义突变)是已知的。此外,2个突变(无义突变和剪接缺陷)可能是新生的。
已开发出MRF-SSCP方法来分析由长链RT-PCR和巢式PCR技术产生的PCR产物,以筛选全长cDNA中的PKD1突变。鉴定出的5个突变均在该基因的重复区域内,其中3个是新的。新生PKD1突变的存在表明该基因易于发生突变。